Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on D Amino Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106543017B reveals a mild hydrogenation process for high-purity pharmaceutical intermediates, offering significant supply chain and cost advantages.
Patent CN104693057A details high-purity 2,5-diaminoterephthalic acid production. Offers cost reduction and supply chain reliability for polymer manufacturing.
Novel enzymatic resolution route for high-purity Alzheimer's intermediate. Reduces cost and improves scalability for pharma manufacturing.
Novel patent CN119350432B details efficient Fmoc-Ile-Aib-OH synthesis. Offers cost reduction and high purity for pharmaceutical intermediate manufacturing supply chains.
Patent CN102586384B reveals a novel deracemization method for D-amino acids using Alcaligenes faecalis, offering high optical purity and simplified downstream processing for pharmaceutical supply chains.
Patent CN101003822A reveals immobilized enzyme hydrolysis for high-purity D-amino acids. Offers scalable production and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN106191151B reveals a novel biotransformation route for high-purity D-lysine and 5-aminovaleric acid co-production, offering significant supply chain and cost advantages for global manufacturers.
Patent CN103074409A details a novel enzymatic resolution method for high-purity halogenated alpha-amino acids, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN102942542A details a cost-effective Ru-catalyzed route for 4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxylic acid, offering significant supply chain advantages.
Patent CN102432485B details a novel Rh-catalyzed four-component reaction for high-purity alpha,beta-diamino acid derivatives, offering significant cost reduction in API manufacturing.
Patent CN110317849B reveals a high-yield enzymatic method for producing chiral tetrahydroisoquinoline intermediates, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN102702042B reveals Pd/Al2O3 fixed-bed process for CLT acid. Enhances purity and reduces waste for pigment manufacturing supply chains.
Patent CN108300744A reveals enzymatic synthesis for high purity D-heterocyclic amino acids. This technology reduces cost and improves supply chain reliability for global pharmaceutical buyers seeking scalable intermediates.
Patent CN1916164A reveals high-yield hydantoinase method. Reduces cost in API manufacturing. Reliable pharmaceutical intermediate supplier for D-amino acids.
Advanced synthesis of 5-amino-2,4-diiodo-1,3-phthalic acid via selective deiodination. Reliable pharmaceutical intermediate supplier for contrast agent quality control.
Discover the patented preparation of alpha-chlorinated carbonates for amino acid protection. A breakthrough in cost reduction and scalability for pharmaceutical manufacturing.
Patent CN1283178A reveals a novel direct halogenation route for high-purity S-phenylcysteine derivatives, offering significant cost reduction in API manufacturing and scalable supply solutions.
Novel patent CN109824547A enables safer synthesis of double protected amino acids. Achieve high purity and reduced costs for pharmaceutical intermediate manufacturing supply chains.
Patent CN102617382B details a novel synthesis for flexible diaminofluorene derivatives, offering superior toughness for epoxy resins and polyimides with scalable manufacturing processes.
Patent CN111269132B reveals a biomimetic pyridoxal catalytic route for high-purity chiral amino acids, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.